Global Autologous Cell Therapy Market 2017-2021

自家細胞治療の世界市場2017-2021

◆タイトル:Global Autologous Cell Therapy Market 2017-2021
◆商品コード:IRTNTR12349
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年6月7日
◆ページ数:92
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、自家細胞治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、自家細胞治療の世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Autologous Cell Therapy Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

Technavio’s analysts forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Brainstorm Cell Therapeutics
• Holostem Advanced Therapies
• Osiris Therapeutics
• Valeant
• Vericel Corporation

[Other prominent vendors]
• AbbVie
• American CryoStem
• AM-Pharma
• Anterogen
• apceth Biopharma
• Astellas Pharma
• Athersys
• Baxter International
• Beike Biotechnology
• BIOTIME
• bluebird bio
• Bristol-Myers Squibb
• Brainxell
• Caladrius Biosciences
• Cellular Biomedicine Group
• Cellular Dynamics International (a subsidiary of Fujifilm)
• Cesca Therapeutics
• CHA Biotech
• Chugai Pharmaceutical
• Citospin
• Corestem
• Cytori Therapeutics
• Daiichi Sankyo
• Fujifilm
• Gamida Cell
• Global Stem Cells Group
• Grupo Ferrer Internacional
• GlaxoSmithKline
• Hemostemix
• Histocell
• International Stem Cell
• Ivy Institute of Stem Cells
• Japan Regenerative Medicine
• Kangstem Biotech
• Kiadis Pharma
• Laboratorios Salvat
• MEDIPOST
• Mesoblast
• Nuo Therapeutics
• Opsis Therapeutics
• Pharmicell
• Pluristem Therapeutics
• Promethera Biosciences
• Q Therapeutics
• ReNeuron
• RHEACELL
• Salus Medical Solutions
• Sangamo Therapeutics
• Shire
• Steminent Biotherapeutics
• Sumitomo Dainippon Pharma
• Taiwan Bio Therapeutics
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries
• Thoratec Corporation
• TiGenix
• Translational Biosciences
• TWO CELLS
• U.S. Stem Cell
• ViaCyte
• VistaGen Therapeutics

[Market driver]
• Increasing demand for effective drugs for cardiac and degenerative disorders
• For a full, detailed list, view our report

[Market challenge]
• Critical ethical challenges with respect to stem cell research
• For a full, detailed list, view our report

[Market trend]
• Private funding will fuel market growth
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Pipeline Landscape

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Market segmentation by application
• Oncology
• Musculoskeletal disorders
• Dermatology

PART 08: Market Segmentation by therapy
• Autologous stem cell therapy
• Autologous cellular immunotherapies

PART 09: Geographical segmentation
• Autologous cell therapy market in Americas
• Autologous cell therapy market in EMEA
• Autologous cell therapy market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Private funding will fuel market growth
• Development of stem cell therapies by new regions
• Increasing focus on development of drugs for emerging applications

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Brainstorm Cell Therapeutics
• Holostem Advanced Therapies
• Osiris Therapeutics
• Valeant
• Vericel Corporation
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Ethical issues faced by various institutes at different phases of research
Exhibit 02: Key Pipeline landscape
Exhibit 03: Global autologous cell therapy market: Snapshot
Exhibit 04: Global autologous cell therapy market 2016-2021 ($ millions)
Exhibit 05: Global autologous cell therapy market: Opportunity analysis
Exhibit 06: Five forces analysis
Exhibit 07: Global autologous cell therapy market segmentation by application 2016
Exhibit 08: Overview of oncology segment in global autologous cell therapy market
Exhibit 09: Overview of musculoskeletal disorders segment in global autologous cell therapy market
Exhibit 10: Overview of dermatology segment in global autologous cell therapy market
Exhibit 11: Global autologous cell therapy market segmentation by therapy 2016
Exhibit 12: Global autologous stem cell therapy market 2016-2021 ($ millions)
Exhibit 13: Global autologous cellular immunotherapies therapy market 2016-2021 ($ millions)
Exhibit 14: Segmentation of global autologous cell therapy market based on geography 2016 and 2021
Exhibit 15: Global autologous cell therapy market revenue by geography 2016-2021 ($ millions)
Exhibit 16: Market scenario in Americas
Exhibit 17: Autologous cell therapy market in Americas 2016-2021 ($ millions)
Exhibit 18: Market scenario in EMEA
Exhibit 19: Autologous cell therapy market in EMEA 2016-2021 ($ millions)
Exhibit 20: Market scenarios in APAC
Exhibit 21: Autologous cell therapy market in APAC 2016-2021 ($ millions)
Exhibit 22: Competitive structure analysis of global stem cell therapy market 2016
Exhibit 23: Strategic success factors of companies in global autologous cell therapy market
Exhibit 24: Brainstorm Cell Therapeutics: Key highlights
Exhibit 25: Brainstorm Cell Therapeutics: Strength assessment
Exhibit 26: Brainstorm Cell Therapeutics: Strategy assessment
Exhibit 27: Brainstorm Cell Therapeutics: Opportunity assessment
Exhibit 28: Holostem Advanced Therapies: Key highlights
Exhibit 29: Holostem Advanced Therapies: Strength assessment
Exhibit 30: Holostem Advanced Therapies: Strategy assessment
Exhibit 31: Holostem Advanced Therapies: Opportunity assessment
Exhibit 32: Osiris Therapeutics: Key highlights
Exhibit 33: Osiris Therapeutics: Strength assessment
Exhibit 34: Osiris Therapeutics: Strategy assessment
Exhibit 35: Osiris Therapeutics: Opportunity assessment
Exhibit 36: Valeant: Key highlights
Exhibit 37: Valeant: Strength assessment
Exhibit 38: Valeant: Strategy assessment
Exhibit 39: Valeant: Opportunity assessment
Exhibit 40: Vericel Corporation: Key highlights
Exhibit 41: Vericel Corporation: Strength assessment
Exhibit 42: Vericel Corporation: Strategy assessment
Exhibit 43: Vericel Corporation: Opportunity assessment



【掲載企業】

Brainstorm Cell Therapeutics, Holostem Advanced Therapies, Osiris Therapeutics, Valeant, Vericel, AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, Brainxell, Caladrius Biosciences, Cellular Biomedicine, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, and VistaGen Therapeutics.

【資料のキーワード】

自家細胞治療

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[自家細胞治療の世界市場2017-2021] (Global Autologous Cell Therapy Market 2017-2021 / IRTNTR12349)販売に関する免責事項
[自家細胞治療の世界市場2017-2021] (Global Autologous Cell Therapy Market 2017-2021 / IRTNTR12349)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆